Dare Bioscience, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Dare Bioscience, Inc. (DARE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-26
- Dare Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$1.80M, a 175.00% decline from fiscal 2024.
- Dare Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $2.40M, a 70.00% decline from fiscal 2023.
- Dare Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $8.00M, a 77.78% increase from fiscal 2022.
- Dare Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $4.50M, a 68.97% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.80M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $2.40M 10-K · filed 2025-03-31 | |
| 2023-12-31 | $8.00M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $4.50M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $14.50M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $22.10M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $4.10M 10-K · filed 2021-03-30 | |
| 2018-12-31 | $55.60M 10-K · filed 2020-03-27 | $3.10M 10-K · filed 2019-04-01 |
| 2017-12-31 | $55.60M 10-K · filed 2019-04-01 | $55.90M 10-K · filed 2018-03-28 |
| 2016-12-31 | $15.50M 10-K/A · filed 2017-06-13 | |
| 2015-12-31 | $15.60M 10-K/A · filed 2017-06-13 | |
| 2014-12-31 | $7.60M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $7.10M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |